These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 719601)

  • 1. 24-hour infusion of cis-platinum in head and neck cancers.
    Jacobs C; Bertino JR; Goffinet DR; Fee WE; Goode RL
    Cancer; 1978 Nov; 42(5):2135-40. PubMed ID: 719601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-platinum chemotherapy in head and neck cancers.
    Jacobs C; Bertino JR; Goffinet DR; Fee WE; Goode RL
    Otolaryngology; 1978; 86(5):ORL-780-3. PubMed ID: 114948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck.
    Decker DA; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh JJ; Weaver A; Al-Sarraf M
    Cancer; 1983 Apr; 51(8):1353-5. PubMed ID: 6681726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer.
    Creagan ET; O'Fallon JR; Woods JE; Ingle JN; Schutt AJ; Nichols WC
    Cancer; 1983 Jun; 51(11):2020-3. PubMed ID: 6682349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck.
    Weaver A; Fleming S; Vandenberg H; Drelichman A; Jacobs J; Kinzie J; Loh JJ; Al-Sarraf M
    Head Neck Surg; 1982; 4(5):370-3. PubMed ID: 7201459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I study.
    Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Diergarten K; Rastetter J; Hanauske AR
    Oncology; 1997; 54(2):89-95. PubMed ID: 9075777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
    Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion.
    Hong WK; Shapshay SM; Bhutani R; Craft ML; Ucmakli A; Yamaguchi KT; Vaughan CW; Strong MS
    Cancer; 1979 Jul; 44(1):19-25. PubMed ID: 88255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N
    J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
    Kish JA; Ensley JF; Jacobs J; Weaver A; Cummings G; Al-Sarraf M
    Cancer; 1985 Dec; 56(12):2740-4. PubMed ID: 3902199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma.
    Choksi AJ; Hong WK; Dimery IW; James P; Guillamondegui OM; Byers RM
    Cancer; 1988 Mar; 61(5):909-12. PubMed ID: 3338056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
    Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
    J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.
    Wittes RE; Cvitkovic E; Shah J; Gerold FP; Strong EW
    Cancer Treat Rep; 1977; 61(3):359-66. PubMed ID: 872136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
    Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
    J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer.
    Hitt R; Hornedo J; Colomer R; Hidalgo M; Brandariz A; Peña M; Vicent JA; Cortés-Funes H
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-58-S2-64. PubMed ID: 9045339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.
    Kish J; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh J; Weaver A; Al-Sarraf M
    Cancer Treat Rep; 1982 Mar; 66(3):471-4. PubMed ID: 7037180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.